成年早期高雄激素血症是中年糖代谢异常的独立危险因素
该前瞻性研究纳入5889名女性,在31岁和46岁时评估血清睾酮与游离雄激素指数(FAI),分析其与胰岛素抵抗、胰岛素分泌及糖代谢异常(AGM)的关系。结果显示,31岁时高雄激素血症女性在校正BMI后HOMA-IR、HOMA-B及空腹胰岛素均升高;31岁最高睾酮四分位及31岁、46岁最高两个FAI四分位与AGM风险升高独立于BMI相关,SHBG与AGM呈负相关。
要点
- 31岁高雄激素血症与胰岛素抵抗、β细胞功能及空腹胰岛素升高相关。
- 31岁最高睾酮四分位及31岁、46岁高FAI与AGM风险升高独立于BMI相关。
- SHBG与AGM风险呈负相关,提示其可能具有保护性关联。
核心结论
- 成年早期及中年高雄激素血症和低SHBG与糖代谢异常相关,且独立于BMI。
研究设计与样本
- 前瞻性研究,纳入5889名女性,分别在31岁和46岁随访评估。
主要发现
- 31岁时高雄激素血症女性校正BMI后HOMA-IR(P=0.002)、HOMA-B(P=0.007)及空腹胰岛素(P=0.03)均高于正常雄激素女性。
- 46岁时高雄激素血症女性空腹血糖(P=0.07)和糖化血红蛋白A1(P=0.07)有升高趋势但未达统计学显著。
- 31岁最高睾酮四分位与AGM风险升高相关(OR=1.80;95%CI,1.15-2.82)。
- 31岁(Q4:OR=3.76;95%CI,2.24-6.32)和46岁(Q4:OR=2.79;95%CI,1.74-4.46)最高两个FAI四分位与AGM风险升高相关。
- SHBG与AGM呈负相关(31岁Q4:OR=0.37;95%CI,0.23-0.60;46岁Q4:OR=0.28;95%CI,0.17-0.44)。
临床怎么用
- 对成年早期高雄激素血症或低SHBG女性,应关注糖代谢筛查,即使BMI正常。
- 评估雄激素水平时可将FAI和SHBG纳入糖代谢风险分层参考。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: The role of androgen excess as a contributing factor to abnormal glucose metabolism (AGM) and insulin resistance in women remains controversial. OBJECTIVE: To investigate whether hyperandrogenemia (HA) estimated by serum testosterone (T) level and free androgen index (FAI) at ages 31 and 46 years is associated with insulin resistance, insulin secretion and AGM by age 46. DESIGN: Prospective study including 5889 females followed at ages 31 and 46 years. SETTING: General community. PARTICIPANTS: Women with HA were compared with normoandrogenic women at ages 31 and 46 years. INTERVENTION: None. MAIN OUTCOME MEASUREMENTS: AGM, including prediabetes and type 2 diabetes mellitus, homeostatic model assessments of insulin resistance (HOMA-IR) and of pancreatic β-cell function (HOMA-B). RESULTS: At age 31 years, HA women displayed increased HOMA-IR (P = 0.002), HOMA-B (P = 0.007), and higher fasting insulin (P = 0.03) than normoandrogenic women after adjusting for body mass index (BMI). At age 46 years, there was a nonsignificant trend toward higher fasting glucose (P = 0.07) and glycated hemoglobin A1 (P = 0.07) levels in HA women. Women in the highest T quartile (odds ratio [OR] = 1.80; 95%CI, 1.15-2.82) at age 31 years and in the 2 highest FAI quartiles at ages 31 (Q4: OR = 3.76; 95% CI, 2.24-6.32) and 46 (Q4: OR = 2.79; 95% CI, 1.74-4.46) years had increased risk for AGM, independently of BMI, when compared with women in Q1. SHBG was inversely associated with AGM (at age 31 years: Q4: OR = 0.37; 95% CI, 0.23-0.60, at age 46 years: Q4: OR = 0.28; 95% CI, 0.17-0.44). CONCLUSION: Hyperandrogenemia and low SHBG in early and middle age associates with AGM independently of BMI.
引用
- Tuorila K, Ollila MM, Järvelin MR, et al. Hyperandrogenemia in Early Adulthood Is an Independent Risk Factor for Abnormal Glucose Metabolism in Middle Age. J Clin Endocrinol Metab. 2021. PMID: 34153097. doi:10.1210/clinem/dgab456
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。